Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLESP Block vs PENG+LFCN Block for Postoperative Analgesia in Total Hip Arthroplasty
NCT07771829Recruiting
- Sponsor
- Huazhong University of Science and Technology
- Start
- Aug 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Postoperative 24-Hour Cumulative Opioid Consumption. Started Aug 2026; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07771829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07771829.